Skip to main content
一致魔芋 logo

一致魔芋 — Investor Relations & Filings

Ticker · 920273 ISIN · CNE100005SP4 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 449 across all filing types
Latest filing 2023-08-17 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920273

About 一致魔芋

http://www.easykonjac.com/

Hubei Yizhi Konjac Biotechnology Co., Ltd. specializes in the research, development, and large-scale production of konjac-based ingredients and consumer products. The company’s core portfolio includes konjac flour, purified glucomannan, and dietary fibers utilized as functional additives, stabilizers, and gelling agents. Beyond food applications, it develops specialized konjac derivatives for the cosmetic and pharmaceutical sectors, including biodegradable materials and moisturizing components. The firm maintains an integrated industrial chain encompassing raw material sourcing and advanced deep-processing technologies. Its products are designed to meet global standards for health-oriented applications, focusing on low-calorie, high-fiber solutions for weight management and digestive wellness. Through continuous biotechnological innovation, the company provides versatile raw materials and finished goods to diverse international markets.

Recent filings

Filing Released Lang Actions
第三届监事会第六次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of 湖北一致魔芋生物科技股份有限公司 regarding several agenda items including approval of the 2023 half-year report and its summary, a special report on the use of raised funds, and a share repurchase plan. It includes voting results and procedural details but does not contain the actual half-year financial report or detailed financial data. It references that the full reports are disclosed separately on the Beijing Stock Exchange website. The document is relatively short (1614 characters) and serves as an official announcement of meeting resolutions rather than the report itself. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and meeting resolution notice, not as an Interim Report (IR) or Share Repurchase (POS) filing itself.
2023-08-17 Chinese
2023年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is a detailed report covering a six-month period (January 1, 2023 to June 30, 2023) for 湖北一致魔芋生物科技股份有限公司. It includes sections such as company overview, accounting data and operating conditions, major events, share changes and financing, changes in directors and senior management, financial accounting reports, and a directory of reference documents. The document contains extensive financial data including revenue, profit, assets, liabilities, and detailed business descriptions. It explicitly states it is a "半年度报告" (half-year report) and includes unaudited financial statements and management assurances. The length is about 15,000 characters, indicating a full report rather than a brief announcement. The content and structure align with an Interim / Quarterly Report, which is a comprehensive financial report for a period shorter than a full fiscal year. Therefore, the document should be classified as an Interim / Quarterly Report (IR). H1 2023
2023-08-17 Chinese
出售全资子公司股权的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the sale of a wholly-owned subsidiary's equity by 湖北一致魔芋生物科技股份有限公司. It details the transaction overview, parties involved, asset valuation, approval by the board, and the impact on the company's consolidated financial statements. It explicitly states that the transaction does not constitute a major asset restructuring and includes information about the transaction agreement and risk warnings. The document is a formal disclosure of a capital transaction involving equity transfer, not a full financial report, earnings release, or management discussion. It fits the category of Capital/Financing Update (CAP) as it updates shareholders and the market on a significant financing-related transaction (sale of subsidiary equity). The document length is 4166 characters, which is sufficient for a detailed announcement but not a full annual or interim report. Therefore, the appropriate classification is CAP with high confidence.
2023-06-25 Chinese
第三届董事会第六次会议决议公告
Board/Management Information Classification · 100% confidence The document is a formal announcement of the resolutions passed at the sixth meeting of the third board of directors of 湖北一致魔芋生物科技股份有限公司. It details the meeting's time, place, attendance, and the approval of a proposal to sell a wholly-owned subsidiary. There is no financial data or report content, only a board decision announcement. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors. The document length is short and focused on the board meeting resolution, not a full report or financial statement.
2023-06-25 Chinese
独立董事关于第三届董事会第六次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion regarding a specific board meeting resolution about the sale of a wholly-owned subsidiary's equity. It includes statements about the board meeting date, legal compliance, and the directors' independent judgment on the matter. This is a governance-related announcement concerning board decisions and oversight, not a full financial report, audit, or earnings release. It does not contain financial statements or detailed financial data. Therefore, it fits best under Board/Management Information (MANG). The document length is short and focused on board opinions, not a report publication or regulatory filing.
2023-06-25 Chinese
2022年年度权益分派实施公告
Notice of Dividend Amount Classification · 100% confidence The document is an announcement regarding the implementation of the 2022 annual equity distribution (dividend) plan of 湖北一致魔芋生物科技股份有限公司. It details the dividend amount, payment dates, tax treatment, and record dates. It references the shareholders' meeting approval but does not contain full financial statements or detailed financial performance data. The document length is short (1246 characters) and focuses on dividend distribution specifics rather than a full report. Therefore, it fits the category of Notice of Dividend Amount (DIV).
2023-05-29 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.